Bicara Therapeutics (BCAX) Q1 2025 Earnings

Mar 27Confirmed
Q4 2024
Q1 2025
-1.6
-1.18
-0.75
-0.33

Details

Expected EPS
-0.3292
Actual EPS
-0.39
Surprise EPS
-0.06
Surprise Percent
-18.47%

Description

⁨Bicara Therapeutics⁩ (⁦BCAX⁩) has reported earnings of ⁦-0.39⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts